{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:10:54Z","timestamp":1789031454985,"version":"build-2803163510"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"DOI":"10.1007\/s11910-026-01514-1","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:57:59Z","timestamp":1789030679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic Diagnosis in Epilepsy: Implications for Clinical Management"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2108-7365","authenticated-orcid":false,"given":"Krista S.","family":"Schatz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-6123","authenticated-orcid":false,"given":"Dawn B.","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5315-2310","authenticated-orcid":false,"given":"Christa W.","family":"Habela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"1514_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(18)30454-X","volume":"18","author":"E Beghi","year":"1990","unstructured":"Beghi E, Giussani G, Nichols E, Abd-Allah F, Abdela J, Abdelalim A, et al. Global, regional, and national burden of epilepsy, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 1990;18:357\u201375. https:\/\/doi.org\/10.1016\/S1474-4422(18)30454-X.","journal-title":"Lancet Neurol"},{"key":"1514_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00415-025-13002-6","volume":"272","author":"X Xu","year":"2025","unstructured":"Xu X, Sha L, Basang S, Peng A, Zhou X, Liu Y, et al. Mortality in patients with epilepsy: a systematic review. J Neurol. 2025;272:291. https:\/\/doi.org\/10.1007\/s00415-025-13002-6.","journal-title":"J Neurol"},{"key":"1514_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475\u201382. https:\/\/doi.org\/10.1111\/epi.12550.","journal-title":"Epilepsia"},{"key":"1514_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/j.1528-1167.2011.03051.x","volume":"52","author":"SD Shorvon","year":"2011","unstructured":"Shorvon SD. The causes of epilepsy: Changing concepts of etiology of epilepsy over the past 150 years. Epilepsia. 2011;52:1033\u201344. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03051.x.","journal-title":"Epilepsia"},{"key":"1514_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrneurol.2014.62","volume":"10","author":"RH Thomas","year":"2014","unstructured":"Thomas RH, Berkovic SF. The hidden genetics of epilepsy\u2014a clinically important new paradigm. Nat Rev Neurol. 2014;10:283\u201392. https:\/\/doi.org\/10.1038\/nrneurol.2014.62.","journal-title":"Nat Rev Neurol"},{"key":"1514_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ng1547","volume":"37","author":"KL Gunderson","year":"2005","unstructured":"Gunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS. A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet. 2005;37:549\u201354. https:\/\/doi.org\/10.1038\/ng1547.","journal-title":"Nat Genet"},{"key":"1514_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2019.02.003","volume":"177","author":"J Shendure","year":"2019","unstructured":"Shendure J, Findlay GM, Snyder MW. Genomic Medicine\u2013Progress, Pitfalls, and Promise. Cell. 2019;177:45\u201357. https:\/\/doi.org\/10.1016\/j.cell.2019.02.003.","journal-title":"Cell"},{"key":"1514_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/epi.17141","volume":"63","author":"BR Sheidley","year":"2022","unstructured":"Sheidley BR, Malinowski J, Bergner AL, Bier L, Gloss DS, Mu W, et al. Genetic testing for the epilepsies: a systematic review. Epilepsia. 2022;63:375\u201387. https:\/\/doi.org\/10.1111\/epi.17141.","journal-title":"Epilepsia"},{"key":"1514_CR9","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/gim.2015.186","volume":"18","author":"KL Helbig","year":"2016","unstructured":"Helbig KL, Farwell Hagman KD, Shinde DN, Mroske C, Powis Z, Li S, et al. Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy. Genet Sci. 2016;18:898\u2013905. https:\/\/doi.org\/10.1038\/gim.2015.186.","journal-title":"Genet Sci"},{"key":"1514_CR10","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1038\/s41467-023-39539-6","volume":"14","author":"L Montanucci","year":"2023","unstructured":"Montanucci L, Lewis-Smith D, Collins RL, Niestroj L-M, Parthasarathy S, Xian J, et al. Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals. Nat Commun Nat Publishing Group. 2023;14:4392. https:\/\/doi.org\/10.1038\/s41467-023-39539-6.","journal-title":"Nat Commun Nat Publishing Group"},{"key":"1514_CR11","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1212\/WNL.0b013e3182a95829","volume":"81","author":"SA Mullen","year":"2013","unstructured":"Mullen SA, Carvill GL, Bellows S, Bayly MA, Berkovic SF, Dibbens LM, et al. Copy number variants are frequent in genetic generalized epilepsy with intellectual disability. Neurology. 2013;81:1507\u201314. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a95829.","journal-title":"Neurology"},{"key":"1514_CR12","doi-asserted-by":"publisher","first-page":"e218013","DOI":"10.1212\/WNL.0000000000218013","volume":"106","author":"F Riccardi","year":"2026","unstructured":"Riccardi F, Desnous B, Borloz E, Lepine A, Lacoste C, Mignon-Ravix C, et al. Burst-Suppression EEG in Early Infantile Developmental and Epileptic Encephalopathies. Neurol Wolters Kluwer. 2026;106:e218013. https:\/\/doi.org\/10.1212\/WNL.0000000000218013.","journal-title":"Neurol Wolters Kluwer"},{"key":"1514_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/jgc4.1646","volume":"32","author":"L Smith","year":"2023","unstructured":"Smith L, Malinowski J, Ceulemans S, Peck K, Walton N, Sheidley BR, et al. Genetic testing and counseling for the unexplained epilepsies: An evidence-based practice guideline of the National Society of Genetic Counselors. J Genet Couns. 2023;32:266\u201380. https:\/\/doi.org\/10.1002\/jgc4.1646.","journal-title":"J Genet Couns"},{"key":"1514_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.seizure.2026.05.029","volume":"140","author":"P Surabhi","year":"2026","unstructured":"Surabhi P, Fasaludeen A, Jose M, Manisha K, Koshy KG, Sundaram S, et al. Does genetic diagnosis influence long-term seizure and developmental outcomes in childhood developmental and epileptic encephalopathies? A longitudinal audit. Seizure: Eur J Epilepsy. 2026;140:104\u201311. https:\/\/doi.org\/10.1016\/j.seizure.2026.05.029.","journal-title":"Seizure: Eur J Epilepsy"},{"key":"1514_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1006\/geno.1994.1420","volume":"22","author":"O Steinlein","year":"1994","unstructured":"Steinlein O, Smigrodzki R, Lindstrom J, Anand R, K\u00f6hler M, Tocharoentanaphol C, et al. Refinement of the Localization of the Gene for Neuronal Nicotinic Acetylcholine Receptor \u03b14 Subunit (CHRNA4) to Human Chromosome 20q13.2-q13.3. Genomics. 1994;22:493\u20135. https:\/\/doi.org\/10.1006\/geno.1994.1420.","journal-title":"Genomics"},{"key":"1514_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1006\/nbdi.1994.0012","volume":"1","author":"C Beck","year":"1994","unstructured":"Beck C, Moulard B, Steinlein O, Guipponi M, Vallee L, Montpied P, et al. A nonsense mutation in the \u03b14 subunit of the nicotinic acetylcholine receptor (CHRNA4) cosegregates with 20q-linked benign neonatal familial convulsions (EBNI). Neurobiol Dis. 1994;1:95\u20139. https:\/\/doi.org\/10.1006\/nbdi.1994.0012.","journal-title":"Neurobiol Dis"},{"key":"1514_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.seizure.2016.11.030","volume":"44","author":"J Wang","year":"2017","unstructured":"Wang J, Lin Z-J, Liu L, Xu H-Q, Shi Y-W, Yi Y-H, et al. Epilepsy-associated genes. Seizure. 2017;44:11\u201320. https:\/\/doi.org\/10.1016\/j.seizure.2016.11.030.","journal-title":"Seizure"},{"key":"1514_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.seizure.2023.09.021","volume":"116","author":"M-W Zhang","year":"2024","unstructured":"Zhang M-W, Liang X-Y, Wang J, Gao L-D, Liao H-J, He Y-H, et al. Epilepsy-associated genes: an update. Seizure: Eur J Epilepsy. 2024;116:4\u201313. https:\/\/doi.org\/10.1016\/j.seizure.2023.09.021.","journal-title":"Seizure: Eur J Epilepsy"},{"key":"1514_CR19","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/epi.17547","volume":"64","author":"KL Oliver","year":"2023","unstructured":"Oliver KL, Scheffer IE, Bennett MF, Grinton BE, Bahlo M, Berkovic SF. Genes4Epilepsy: An epilepsy gene resource. Epilepsia. 2023;64:1368\u201375. https:\/\/doi.org\/10.1111\/epi.17547.","journal-title":"Epilepsia"},{"key":"1514_CR20","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1212\/01.wnl.0000345393.53132.8c","volume":"72","author":"K Vahedi","year":"2009","unstructured":"Vahedi K, Depienne C, Le Fort D, Riant F, Chaine P, Trouillard O, et al. Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations. Neurology. 2009;72:1178\u201383. https:\/\/doi.org\/10.1212\/01.wnl.0000345393.53132.8c.","journal-title":"Neurology"},{"key":"1514_CR21","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1093\/brain\/awv317","volume":"138","author":"D Ebrahimi-Fakhari","year":"2015","unstructured":"Ebrahimi-Fakhari D, Saffari A, Westenberger A, Klein C. The evolving spectrum of PRRT2-associated paroxysmal diseases. Brain. 2015;138:3476\u201395. https:\/\/doi.org\/10.1093\/brain\/awv317.","journal-title":"Brain"},{"key":"1514_CR22","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/s41593-024-01747-8","volume":"27","author":"Epi25 Collaborative","year":"2024","unstructured":"Epi25 Collaborative. Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes. Nat Neurosci. 2024;27:1864\u201379. https:\/\/doi.org\/10.1038\/s41593-024-01747-8.","journal-title":"Nat Neurosci"},{"key":"1514_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng.835","volume":"43","author":"BJ O\u2019Roak","year":"2011","unstructured":"O\u2019Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet. 2011;43:585\u20139. https:\/\/doi.org\/10.1038\/ng.835.","journal-title":"Nat Genet"},{"key":"1514_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature11011","volume":"485","author":"BM Neale","year":"2012","unstructured":"Neale BM, Kou Y, Liu L, Ma\u2019ayan A, Samocha KE, Sabo A, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012;485:242\u20135. https:\/\/doi.org\/10.1038\/nature11011.","journal-title":"Nature"},{"key":"1514_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature12439","volume":"501","author":"AS Allen","year":"2013","unstructured":"Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, et al. De novo mutations in epileptic encephalopathies. Nat Nat Publishing Group. 2013;501:217\u201321. https:\/\/doi.org\/10.1038\/nature12439.","journal-title":"Nat Nat Publishing Group"},{"key":"1514_CR26","doi-asserted-by":"publisher","first-page":"356","DOI":"10.5698\/1535-7597.18.6.356","volume":"18","author":"P Perucca","year":"2018","unstructured":"Perucca P. Genetics of Focal Epilepsies: What do we know and where are we Heading? Epilepsy Curr. SAGE Publications Inc. 2018;18:356\u201362. https:\/\/doi.org\/10.5698\/1535-7597.18.6.356.","journal-title":"SAGE Publications Inc"},{"key":"1514_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41525-018-0052-9","volume":"3","author":"S Oates","year":"2018","unstructured":"Oates S, Tang S, Rosch R, Lear R, Hughes EF, Williams RE, et al. Incorporating epilepsy genetics into clinical practice: a 360\u00b0evaluation. npj Genomic Med Nat Publishing Group. 2018;3:13. https:\/\/doi.org\/10.1038\/s41525-018-0052-9.","journal-title":"npj Genomic Med Nat Publishing Group"},{"key":"1514_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2017.02.001","volume":"131","author":"P Perucca","year":"2017","unstructured":"Perucca P, Scheffer IE, Harvey AS, James PA, Lunke S, Thorne N, et al. Real-world utility of whole exome sequencing with targeted gene analysis for focal epilepsy. Epilepsy Res. 2017;131:1\u20138. https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.02.001.","journal-title":"Epilepsy Res"},{"key":"1514_CR29","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/ana.26609","volume":"93","author":"JH Kim","year":"2023","unstructured":"Kim JH, Park J-H, Lee J, Park JW, Kim HJ, Chang WS, et al. Ultra-Low Level Somatic Mutations and Structural Variations in Focal Cortical Dysplasia Type II. Ann Neurol. 2023;93:1082\u201393. https:\/\/doi.org\/10.1002\/ana.26609.","journal-title":"Ann Neurol"},{"key":"1514_CR30","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/epi.17943","volume":"65","author":"RJ Carton","year":"2024","unstructured":"Carton RJ, Doyle MG, Kearney H, Steward CA, Lench NJ, Rogers A, et al. Somatic variants as a cause of drug-resistant epilepsy including mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia. 2024;65:1451\u201361. https:\/\/doi.org\/10.1111\/epi.17943.","journal-title":"Epilepsia"},{"key":"1514_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020815","volume":"26","author":"JM Schwarz","year":"2025","unstructured":"Schwarz JM, Becker L-L, Wahle M, Fa\u00dfbender J, Thomale U-W, Tietze A, et al. Somatic DNA variants in epilepsy surgery brain samples from patients with lesional epilepsy. Int J Mol Sci. 2025;26:815. https:\/\/doi.org\/10.3390\/ijms26020815.","journal-title":"Int J Mol Sci"},{"key":"1514_CR32","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1111\/epi.18148","volume":"65","author":"MWCB Sanders","year":"2024","unstructured":"Sanders MWCB, Koeleman BPC, Brilstra EH, Jansen FE, Baldassari S, Chipaux M, et al. Somatic variant analysis of resected brain tissue in epilepsy surgery patients. Epilepsia. 2024;65:e209\u201315. https:\/\/doi.org\/10.1111\/epi.18148.","journal-title":"Epilepsia"},{"key":"1514_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad174","volume":"5","author":"R Checri","year":"2023","unstructured":"Checri R, Chipaux M, Ferrand-Sorbets S, Raffo E, Bulteau C, Rosenberg SD, et al. Detection of brain somatic mutations in focal cortical dysplasia during epilepsy presurgical workup. Brain Commun. 2023;5:fcad174. https:\/\/doi.org\/10.1093\/braincomms\/fcad174.","journal-title":"Brain Commun"},{"key":"1514_CR34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1001\/jamaneurol.2023.0473","volume":"80","author":"S Khoshkhoo","year":"2023","unstructured":"Khoshkhoo S, Wang Y, Chahine Y, Erson-Omay EZ, Robert SM, Kiziltug E, et al. Contribution of Somatic Ras\/Raf\/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy. JAMA Neurol. 2023;80:578\u201387. https:\/\/doi.org\/10.1001\/jamaneurol.2023.0473.","journal-title":"JAMA Neurol"},{"key":"1514_CR35","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00401-019-02061-5","volume":"138","author":"S Baldassari","year":"2019","unstructured":"Baldassari S, Ribierre T, Marsan E, Adle-Biassette H, Ferrand-Sorbets S, Bulteau C, et al. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Acta Neuropathol. 2019;138:885\u2013900. https:\/\/doi.org\/10.1007\/s00401-019-02061-5.","journal-title":"Acta Neuropathol"},{"key":"1514_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejpn.2023.09.009","volume":"47","author":"B Straka","year":"2023","unstructured":"Straka B, Splitkova B, Vlckova M, Tesner P, Rezacova H, Krskova L, et al. Genetic testing in children enrolled in epilepsy surgery program. A real-life study. Eur J Paediatr Neurol. 2023;47:80\u20137. https:\/\/doi.org\/10.1016\/j.ejpn.2023.09.009.","journal-title":"Eur J Paediatr Neurol"},{"key":"1514_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.seizure.2026.04.021","volume":"138","author":"S Zhang","year":"2026","unstructured":"Zhang S, Li Q, Xu Z, Qin J, Yang Z, Niu Y. Phenotype and genotype of AKT3-related disorders. Seizure - Eur J Epilepsy Elsevier. 2026;138:147\u201356. https:\/\/doi.org\/10.1016\/j.seizure.2026.04.021.","journal-title":"Seizure - Eur J Epilepsy Elsevier"},{"key":"1514_CR38","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1002\/epi.70088","volume":"67","author":"F Fazekas","year":"2026","unstructured":"Fazekas F, Haboosheh A, Hennebichler B, Roetzer-Pejrimovsky T, Binder J, Reischer T, et al. A novel PTEN variant causing hemimegalencephaly and focal nodular heterotopias in the developing human brain. Epilepsia. 2026;67:e32\u20138. https:\/\/doi.org\/10.1002\/epi.70088.","journal-title":"Epilepsia"},{"key":"1514_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa221","volume":"3","author":"CA Stutterd","year":"2020","unstructured":"Stutterd CA, Brock S, Stouffs K, Fanjul-Fernandez M, Lockhart PJ, McGillivray G, et al. Genetic heterogeneity of polymicrogyria: study of 123 patients using deep sequencing. Brain Commun. 2020;3:fcaa221. https:\/\/doi.org\/10.1093\/braincomms\/fcaa221.","journal-title":"Brain Commun"},{"key":"1514_CR40","doi-asserted-by":"publisher","first-page":"fcaf408","DOI":"10.1093\/braincomms\/fcaf408","volume":"7","author":"S Benichi","year":"2025","unstructured":"Benichi S, Balducci E, Benzakoun J, Ghannam B, Attieh C, Metais A, et al. Clinical and molecular landscape of paediatric cerebral and spinal cavernous malformations. Brain Commun. 2025;7:fcaf408. https:\/\/doi.org\/10.1093\/braincomms\/fcaf408.","journal-title":"Brain Commun"},{"key":"1514_CR41","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1093\/brain\/awac117","volume":"145","author":"D Lai","year":"2022","unstructured":"Lai D, Gade M, Yang E, Koh HY, Lu J, Walley NM, et al. Somatic variants in diverse genes leads to a spectrum of focal cortical malformations. Brain. 2022;145:2704\u201320. https:\/\/doi.org\/10.1093\/brain\/awac117.","journal-title":"Brain"},{"key":"1514_CR42","doi-asserted-by":"publisher","first-page":"10429","DOI":"10.1038\/s41467-024-54911-w","volume":"15","author":"CM Bo\u00dfelmann","year":"2024","unstructured":"Bo\u00dfelmann CM, Leu C, Br\u00fcnger T, Hoffmann L, Baldassari S, Chipaux M, et al. Analysis of 1386 epileptogenic brain lesions reveals association with DYRK1A and EGFR. Nat Commun. 2024;15:10429. https:\/\/doi.org\/10.1038\/s41467-024-54911-w.","journal-title":"Nat Commun"},{"key":"1514_CR43","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/epi.17301","volume":"63","author":"I Najm","year":"2022","unstructured":"Najm I, Lal D, Alonso Vanegas M, Cendes F, Lopes-Cendes I, Palmini A, et al. The ILAE consensus classification of focal cortical dysplasia: an update proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia. 2022;63:1899\u2013919. https:\/\/doi.org\/10.1111\/epi.17301.","journal-title":"Epilepsia"},{"key":"1514_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104098","volume":"81","author":"C Campbell","year":"2022","unstructured":"Campbell C, Leu C, Feng Y-C, Wolking S, Moreau C, Ellis C, et al. The role of common genetic variation in presumed monogenic epilepsies. eBioMedicine. 2022;81:104098. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104098.","journal-title":"eBioMedicine"},{"key":"1514_CR45","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/brain\/awab260","volume":"145","author":"L Skotte","year":"2022","unstructured":"Skotte L, Fadista J, Bybjerg-Grauholm J, Appadurai V, Hildebrand MS, Hansen TF, et al. Genome-wide association study of febrile seizures implicates fever response and neuronal excitability genes. Brain. 2022;145:555\u201368. https:\/\/doi.org\/10.1093\/brain\/awab260.","journal-title":"Brain"},{"key":"1514_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104079","volume":"81","author":"KL Oliver","year":"2022","unstructured":"Oliver KL, Ellis CA, Scheffer IE, Ganesan S, Leu C, Sadleir LG, et al. Common risk variants for epilepsy are enriched in families previously targeted for rare monogenic variant discovery. eBioMedicine. 2022;81:104079. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104079.","journal-title":"eBioMedicine"},{"key":"1514_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07524-z","volume":"9","author":"B Abou-Khalil","year":"2018","unstructured":"Abou-Khalil B, Auce P, Avbersek A, Bahlo M, Balding DJ, Bast T, et al. Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nat Commun. 2018;9:5269. https:\/\/doi.org\/10.1038\/s41467-018-07524-z.","journal-title":"Nat Commun"},{"key":"1514_CR48","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S1474-4422(14)70171-1","volume":"13","author":"Genetic determinants of","year":"2014","unstructured":"Genetic determinants of. common epilepsies: a meta-analysis of genome-wide association studies. Lancet Neurol Elsevier. 2014;13:893\u2013903. https:\/\/doi.org\/10.1016\/S1474-4422(14)70171-1.","journal-title":"Lancet Neurol Elsevier"},{"key":"1514_CR49","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1093\/brain\/awz292","volume":"142","author":"C Leu","year":"2019","unstructured":"Leu C, Stevelink R, Smith AW, Goleva SB, Kanai M, Ferguson L, et al. Polygenic burden in focal and generalized epilepsies. Brain. 2019;142:3473\u201381. https:\/\/doi.org\/10.1093\/brain\/awz292.","journal-title":"Brain"},{"key":"1514_CR50","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1038\/s41467-019-10482-9","volume":"10","author":"A Takata","year":"2019","unstructured":"Takata A, Nakashima M, Saitsu H, Mizuguchi T, Mitsuhashi S, Takahashi Y, et al. Comprehensive analysis of coding variants highlights genetic complexity in developmental and epileptic encephalopathy. Nat Commun. 2019;10:2506. https:\/\/doi.org\/10.1038\/s41467-019-10482-9.","journal-title":"Nat Commun"},{"key":"1514_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105404","volume":"109","author":"KL Oliver","year":"2024","unstructured":"Oliver KL, Scheffer IE, Ellis CA, Grinton BE, Epi4K Consortium, Berkovic SF, et al. Investigating the effect of polygenic background on epilepsy phenotype in \u201cmonogenic\u201d families. EBioMedicine. 2024;109:105404. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105404.","journal-title":"EBioMedicine"},{"key":"1514_CR52","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/epi.70018","volume":"67","author":"R Stevelink","year":"2026","unstructured":"Stevelink R, Piet MM, Bos Y, van \u2019t Slot R, Braun KPJ, Koeleman BPC. Penetrance of pathogenic epilepsy variants is low and shaped by common genetic background. Epilepsia. 2026;67:1398\u2013405. https:\/\/doi.org\/10.1111\/epi.70018.","journal-title":"Epilepsia"},{"key":"1514_CR53","doi-asserted-by":"publisher","unstructured":"Yano ST, Phitsanuwong C. Genetic risk factors for epilepsy: from familial studies to gene discoveries and polygenic risk scores, strides toward unlocking an age-old question in epilepsy. Epilepsy Curr. 2026:15357597251410840. https:\/\/doi.org\/10.1177\/15357597251410840.","DOI":"10.1177\/15357597251410840"},{"key":"1514_CR54","doi-asserted-by":"publisher","unstructured":"Lin Y, Beier CP, Sobiskova Z, Khalid H, Stodberg T, Ng CC, et al. Transfer learning enhances clinical utility of polygenic scores with small, phenotypically refined cohorts. Genome Research [Internet]. Cold Spring Harbor Laboratory Press; 2026. [cited 2026 June 22]. https:\/\/doi.org\/10.1101\/gr.281480.125.","DOI":"10.1101\/gr.281480.125"},{"key":"1514_CR55","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1001\/jamaneurol.2022.3651","volume":"79","author":"D McKnight","year":"2022","unstructured":"McKnight D, Morales A, Hatchell KE, Bristow SL, Bonkowsky JL, Perry MS, et al. Genetic testing to inform epilepsy treatment management from an international study of clinical practice. JAMA Neurol. 2022;79:1267\u201376. https:\/\/doi.org\/10.1001\/jamaneurol.2022.3651.","journal-title":"JAMA Neurol"},{"key":"1514_CR56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/15357597241232881","volume":"25","author":"CW Habela","year":"2024","unstructured":"Habela CW, Schatz K, Kelley SA. Genetic testing in epilepsy: improving outcomes and informing gaps in research. Epilepsy Curr. 2024;25:153\u20137. https:\/\/doi.org\/10.1177\/15357597241232881.","journal-title":"Epilepsy Curr"},{"key":"1514_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pediatrneurol.2022.10.006","volume":"138","author":"I Haviland","year":"2023","unstructured":"Haviland I, Daniels CI, Greene CA, Drew J, Love-Nichols JA, Swanson LC, et al. Genetic Diagnosis Impacts Medical Management for Pediatric Epilepsies. Pediatr Neurol. 2023;138:71\u201380. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2022.10.006.","journal-title":"Pediatr Neurol"},{"key":"1514_CR58","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1038\/s41436-021-01153-6","volume":"23","author":"P Zacher","year":"2021","unstructured":"Zacher P, Mayer T, Brandhoff F, Bartolomaeus T, Le Duc D, Finzel M, et al. The genetic landscape of intellectual disability and epilepsy in adults and the elderly: a systematic genetic work-up of 150 individuals. Genet Sci. 2021;23:1492\u20137. https:\/\/doi.org\/10.1038\/s41436-021-01153-6.","journal-title":"Genet Sci"},{"key":"1514_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.777115","volume":"13","author":"\u00c1 Beltr\u00e1n-Corbellini","year":"2022","unstructured":"Beltr\u00e1n-Corbellini \u00c1, Aledo-Serrano \u00c1, M\u00f8ller RS, P\u00e9rez-Palma E, Garc\u00eda-Morales I, Toledano R, et al. Epilepsy genetics and precision medicine in adults: a new landscape for developmental and epileptic encephalopathies. Front Neurol. 2022;13:777115. https:\/\/doi.org\/10.3389\/fneur.2022.777115.","journal-title":"Front Neurol"},{"key":"1514_CR60","doi-asserted-by":"publisher","first-page":"e650","DOI":"10.1212\/NXG.0000000000000650","volume":"8","author":"D McKnight","year":"2021","unstructured":"McKnight D, Bristow SL, Truty RM, Morales A, Stetler M, Westbrook MJ, et al. Multigene Panel Testing in a Large Cohort of Adults With Epilepsy. Neurol Genet. 2021;8:e650. https:\/\/doi.org\/10.1212\/NXG.0000000000000650.","journal-title":"Neurol Genet"},{"key":"1514_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2024.110174","volume":"163","author":"I Stenshorne","year":"2025","unstructured":"Stenshorne I, Syvertsen MR, Ramm-Pettersen A, Selmer KK, Koht J, Henriksen MW. Impact of genetic testing in developmental and epileptic encephalopathy- parents\u2019 perspective. Epilepsy Behav. 2025;163:110174. https:\/\/doi.org\/10.1016\/j.yebeh.2024.110174.","journal-title":"Epilepsy Behav"},{"key":"1514_CR62","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/epi4.12458","volume":"6","author":"JS Jeffrey","year":"2021","unstructured":"Jeffrey JS, Leathem J, King C, Mefford HC, Ross K, Sadleir LG. Developmental and epileptic encephalopathy: personal utility of a genetic diagnosis for families. Epilepsia Open. 2021;6:149\u201359. https:\/\/doi.org\/10.1002\/epi4.12458.","journal-title":"Epilepsia Open"},{"key":"1514_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.eplepsyres.2015.02.011","volume":"112","author":"DF Vears","year":"2015","unstructured":"Vears DF, Dunn KL, Wake SA, Scheffer IE. It\u2019s good to know: experiences of gene identification and result disclosure in familial epilepsies. Epilepsy Res. 2015;112:64\u201371. https:\/\/doi.org\/10.1016\/j.eplepsyres.2015.02.011.","journal-title":"Epilepsy Res"},{"key":"1514_CR64","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1542\/peds.13.2.140","volume":"13","author":"AD Hunt","year":"1954","unstructured":"Hunt AD, Stokes J, McCRORY WW, Stroud HH. Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics. 1954;13:140\u20135.","journal-title":"Pediatrics"},{"key":"1514_CR65","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1212\/WNL.0000000000001883","volume":"85","author":"HC Mefford","year":"2015","unstructured":"Mefford HC, Zemel M, Geraghty E, Cook J, Clayton PT, Paul K, et al. Intragenic deletions of ALDH7A1 in pyridoxine-dependent epilepsy caused by Alu-Alu recombination. Neurology. 2015;85:756\u201362. https:\/\/doi.org\/10.1212\/WNL.0000000000001883.","journal-title":"Neurology"},{"key":"1514_CR66","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/epi.17274","volume":"63","author":"EC Wirrell","year":"2022","unstructured":"Wirrell EC, Hood V, Knupp KG, Meskis MA, Nabbout R, Scheffer IE, et al. International consensus on diagnosis and management of Dravet syndrome. Epilepsia. 2022;63:1761\u201377. https:\/\/doi.org\/10.1111\/epi.17274.","journal-title":"Epilepsia"},{"key":"1514_CR67","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/brain\/awx054","volume":"140","author":"M Wolff","year":"2017","unstructured":"Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, et al. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain. 2017;140:1316\u201336. https:\/\/doi.org\/10.1093\/brain\/awx054.","journal-title":"Brain"},{"key":"1514_CR68","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1111\/jnc.16103","volume":"168","author":"L Jia","year":"2024","unstructured":"Jia L, Li M, Pachernegg S, Sedo A, Jancovski N, Burbano LE, et al. Variant-specific in vitro neuronal network phenotypes and drug sensitivity in SCN2A developmental and epileptic encephalopathy. J Neurochem. 2024;168:3950\u201361. https:\/\/doi.org\/10.1111\/jnc.16103.","journal-title":"J Neurochem"},{"key":"1514_CR69","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1093\/hmg\/ddad048","volume":"32","author":"R Asadollahi","year":"2023","unstructured":"Asadollahi R, Delvendahl I, Muff R, Tan G, Rodr\u00edguez DG, Turan S, et al. Pathogenic SCN2A variants cause early-stage dysfunction in patient-derived neurons. Hum Mol Genet. 2023;32:2192\u2013204. https:\/\/doi.org\/10.1093\/hmg\/ddad048.","journal-title":"Hum Mol Genet"},{"key":"1514_CR70","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1002\/epi.70100","volume":"67","author":"M Tan","year":"2026","unstructured":"Tan M, Goad BS, Allen M, Rodda J, Richards KL, Ardern-Holmes SL, et al. Mechanisms of SCN2A loss of function do not predict presence or phenotype of epilepsy. Epilepsia. 2026;67:2628\u201353. https:\/\/doi.org\/10.1002\/epi.70100.","journal-title":"Epilepsia"},{"key":"1514_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1159649","author":"X Hu","year":"2023","unstructured":"Hu X, Jing M, Wang Y, Liu Y, Hua Y. Functional analysis of a novel de novo SCN2A variant in a patient with seizures refractory to oxcarbazepine. Front Mol Neurosci [Internet] Front. 2023. https:\/\/doi.org\/10.3389\/fnmol.2023.1159649. [cited 2026 July 1];16.","journal-title":"Front Mol Neurosci [Internet] Front"},{"key":"1514_CR72","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1152\/jn.00309.2021","volume":"127","author":"X-R Yang","year":"2022","unstructured":"Yang X-R, Ginjupalli VKM, Theriault O, Poulin H, Appendino JP, Au PYB, et al. SCN2A-related epilepsy of infancy with migrating focal seizures: report of a variant with apparent gain- and loss-of-function effects. J Neurophysiol. 2022;127:1388\u201397. https:\/\/doi.org\/10.1152\/jn.00309.2021.","journal-title":"J Neurophysiol"},{"key":"1514_CR73","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.202313375","volume":"155","author":"CH Thompson","year":"2023","unstructured":"Thompson CH, Potet F, Abramova TV, DeKeyser J-M, Ghabra NF, Vanoye CG, et al. Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties. J Gen Physiol. 2023;155:e202313375. https:\/\/doi.org\/10.1085\/jgp.202313375.","journal-title":"J Gen Physiol"},{"key":"1514_CR74","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/hmg\/ddac087","volume":"31","author":"DM Echevarria-Cooper","year":"2022","unstructured":"Echevarria-Cooper DM, Hawkins NA, Misra SN, Huffman AM, Thaxton T, Thompson CH, et al. Cellular and behavioral effects of altered NaV1.2 sodium channel ion permeability in Scn2aK1422E mice. Hum Mol Genet. 2022;31:2964\u201388. https:\/\/doi.org\/10.1093\/hmg\/ddac087.","journal-title":"Hum Mol Genet"},{"key":"1514_CR75","doi-asserted-by":"publisher","first-page":"e200380","DOI":"10.1212\/NXG.0000000000200380","volume":"12","author":"Y Li","year":"2026","unstructured":"Li Y, Li J, Li L, Zhang H, Sun X. KCNQ2 Variants in Neonatal Epilepsy. Neurol Genet. 2026;12:e200380. https:\/\/doi.org\/10.1212\/NXG.0000000000200380.","journal-title":"Neurol Genet"},{"key":"1514_CR76","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/epi.12984","volume":"56","author":"T Pisano","year":"2015","unstructured":"Pisano T, Numis AL, Heavin SB, Weckhuysen S, Angriman M, Suls A, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia. 2015;56:685\u201391. https:\/\/doi.org\/10.1111\/epi.12984.","journal-title":"Epilepsia"},{"key":"1514_CR77","doi-asserted-by":"publisher","first-page":"105200","DOI":"10.1016\/j.phrs.2020.105200","volume":"160","author":"MV Soldovieri","year":"2020","unstructured":"Soldovieri MV, Freri E, Ambrosino P, Rivolta I, Mosca I, Binda A, et al. Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy. Pharmacol Res. 2020;160:105200. https:\/\/doi.org\/10.1016\/j.phrs.2020.105200.","journal-title":"Pharmacol Res"},{"key":"1514_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-55285-3","author":"J Xiong","year":"2026","unstructured":"Xiong J, You X, Li H, Chen C, Duan H, Chen S, et al. Assessment of gabapentin efficacy in patients with KCNQ2-developmental epileptic encephalopathy. Sci Rep [Internet] Nat Publishing Group. 2026. https:\/\/doi.org\/10.1038\/s41598-026-55285-3. [cited 2026 July 1].","journal-title":"Sci Rep [Internet] Nat Publishing Group"},{"key":"1514_CR79","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/ajmga.70044","volume":"200","author":"F Zeng","year":"2026","unstructured":"Zeng F, Ye X, Gao Z, Tian F, Shen Y. A Novel KCNQ2 Gain-of-Function Variant I134N Causes Severe Developmental and Epileptic Encephalopathy. Am J Med Genet Part A. 2026;200:1109\u201316. https:\/\/doi.org\/10.1002\/ajmga.70044.","journal-title":"Am J Med Genet Part A"},{"key":"1514_CR80","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1474-4422(22)00077-1","volume":"21","author":"EMP Knight","year":"2022","unstructured":"Knight EMP, Amin S, Bahi-Buisson N, Benke TA, Cross JH, Demarest ST, et al. Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial. Lancet Neurol. 2022;21:417\u201327. https:\/\/doi.org\/10.1016\/S1474-4422(22)00077-1.","journal-title":"Lancet Neurol"},{"key":"1514_CR81","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/WCO.0b013e3283515e4a","volume":"25","author":"EH Kossoff","year":"2012","unstructured":"Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism-based therapies. Curr Opin Neurol. 2012;25:173\u20138. https:\/\/doi.org\/10.1097\/WCO.0b013e3283515e4a.","journal-title":"Curr Opin Neurol"},{"key":"1514_CR82","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1528-1167.2008.01833.x","volume":"49","author":"J Klepper","year":"2008","unstructured":"Klepper J. Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet. Epilepsia. 2008;49:46\u20139. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01833.x.","journal-title":"Epilepsia"},{"key":"1514_CR83","doi-asserted-by":"publisher","unstructured":"Morris S, Blackford R, Lowman W, Fisher B. Managing GLUT 1 deficiency with the ketogenic diet: a retrospective look at seizures, medications, and side effects in a pediatric cohort. J Child Neurol. 2026:08830738251409560. https:\/\/doi.org\/10.1177\/08830738251409560.","DOI":"10.1177\/08830738251409560"},{"key":"1514_CR84","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.seizure.2016.01.011","volume":"35","author":"HR Kass","year":"2016","unstructured":"Kass HR, Winesett SP, Bessone SK, Turner Z, Kossoff EH. Use of dietary therapies amongst patients with GLUT1 deficiency syndrome. Seizure. 2016;35:83\u20137. https:\/\/doi.org\/10.1016\/j.seizure.2016.01.011.","journal-title":"Seizure"},{"key":"1514_CR85","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ana.25506","volume":"86","author":"C Dom\u00ednguez-Gonz\u00e1lez","year":"2019","unstructured":"Dom\u00ednguez-Gonz\u00e1lez C, Madruga-Garrido M, Mavillard F, Garone C, Aguirre-Rodr\u00edguez FJ, Donati MA, et al. Deoxynucleoside Therapy for Thymidine Kinase 2-Deficient Myopathy. Ann Neurol. 2019;86:293\u2013303. https:\/\/doi.org\/10.1002\/ana.25506.","journal-title":"Ann Neurol"},{"key":"1514_CR86","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/ana.24922","volume":"81","author":"C Lopez-Gomez","year":"2017","unstructured":"Lopez-Gomez C, Levy RJ, Sanchez-Quintero MJ, Juanola-Falgarona M, Barca E, Garcia-Diaz B, et al. Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency. Ann Neurol. 2017;81:641\u201352. https:\/\/doi.org\/10.1002\/ana.24922.","journal-title":"Ann Neurol"},{"key":"1514_CR87","doi-asserted-by":"publisher","first-page":"e213908","DOI":"10.1212\/WNL.0000000000213908","volume":"105","author":"C Dom\u00ednguez-Gonz\u00e1lez","year":"2025","unstructured":"Dom\u00ednguez-Gonz\u00e1lez C, Chiang C, Colson A-O, Rebollo Mesa I, Baixauli E, Quan J, et al. Pyrimidine Nucleos(t)ide Therapy in Patients With Thymidine Kinase 2 Deficiency. Neurol Wolters Kluwer. 2025;105:e213908. https:\/\/doi.org\/10.1212\/WNL.0000000000213908.","journal-title":"Neurol Wolters Kluwer"},{"key":"1514_CR88","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1684\/epd.2018.0959","volume":"20","author":"R Stevelink","year":"2018","unstructured":"Stevelink R, Sanders MWCB, Tuinman MP, Brilstra EH, Koeleman BPC, Jansen FE, et al. Epilepsy surgery for patients with genetic refractory epilepsy: a systematic review. Epileptic Disord. 2018;20:99\u2013115. https:\/\/doi.org\/10.1684\/epd.2018.0959.","journal-title":"Epileptic Disord"},{"key":"1514_CR89","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(25)00380-1","volume":"25","author":"R Yardi","year":"2026","unstructured":"Yardi R, Englot DJ, Wu C, Davis K, Baxendale S, Tripathi M, et al. Emerging technologies and strategies in epilepsy surgery: toward personalised medicine. Lancet Neurol. 2026;25:77\u201389. https:\/\/doi.org\/10.1016\/S1474-4422(25)00380-1.","journal-title":"Lancet Neurol"},{"key":"1514_CR90","doi-asserted-by":"publisher","first-page":"e208087","DOI":"10.1212\/WNL.0000000000208087","volume":"102","author":"FA Lado","year":"2024","unstructured":"Lado FA, Ahrens SM, Riker E, Muh CR, Richardson RM, Gray J, et al. Guidelines for Specialized Epilepsy Centers. Neurology. 2024;102:e208087. https:\/\/doi.org\/10.1212\/WNL.0000000000208087.","journal-title":"Neurology"},{"key":"1514_CR91","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.seizure.2023.10.011","volume":"113","author":"J Coryell","year":"2023","unstructured":"Coryell J, Singh R, Ostendorf AP, Eisner M, Alexander A, Eschbach K, et al. Epilepsy surgery in children with genetic etiologies: A prospective evaluation of current practices and outcomes. Seizure. 2023;113:6\u201312. https:\/\/doi.org\/10.1016\/j.seizure.2023.10.011.","journal-title":"Seizure"},{"key":"1514_CR92","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1007\/s00415-023-12174-3","volume":"271","author":"S Alsubhi","year":"2024","unstructured":"Alsubhi S, Berrahmoune S, Dudley RWR, Dufresne D, Simard Tremblay E, Srour M, et al. Utility of genetic testing in the pre-surgical evaluation of children with drug-resistant epilepsy. J Neurol. 2024;271:2503\u20138. https:\/\/doi.org\/10.1007\/s00415-023-12174-3.","journal-title":"J Neurol"},{"key":"1514_CR93","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0887-8994(97)00077-5","volume":"17","author":"T Balslev","year":"1997","unstructured":"Balslev T, Cortez MA, Blaser SI, Haslam RHA. Recurrent seizures in metachromatic leukodystrophy. Pediatr Neurol Elsevier. 1997;17:150\u20134. https:\/\/doi.org\/10.1016\/S0887-8994(97)00077-5.","journal-title":"Pediatr Neurol Elsevier"},{"key":"1514_CR94","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa2405727","volume":"392","author":"F Fumagalli","year":"2025","unstructured":"Fumagalli F, Calbi V, Gallo V, Zambon AA, Recupero S, Ciotti F, et al. Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy. New Engl J Med Mass Med Soc. 2025;392:1609\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2405727.","journal-title":"New Engl J Med Mass Med Soc"},{"key":"1514_CR95","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","volume":"388","author":"M Sessa","year":"2016","unstructured":"Sessa M, Lorioli L, Fumagalli F, Acquati S, Redaelli D, Baldoli C, et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial. Lancet Elsevier. 2016;388:476\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(16)30374-9.","journal-title":"Lancet Elsevier"},{"key":"1514_CR96","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/NEJMoa2400442","volume":"391","author":"F Eichler","year":"2024","unstructured":"Eichler F, Duncan CN, Musolino PL, Lund TC, Gupta AO, Oliveira SD, et al. Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy. New Engl J Med Mass Med Soc. 2024;391:1302\u201312. https:\/\/doi.org\/10.1056\/NEJMoa2400442.","journal-title":"New Engl J Med Mass Med Soc"},{"key":"1514_CR97","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","volume":"377","author":"F Eichler","year":"2017","unstructured":"Eichler F, Duncan C, Musolino PL, Orchard PJ, Oliveira SD, Thrasher AJ, et al. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy. New Engl J Med Mass Med Soc. 2017;377:1630\u20138. https:\/\/doi.org\/10.1056\/NEJMoa1700554.","journal-title":"New Engl J Med Mass Med Soc"},{"key":"1514_CR98","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1111\/dmcn.16373","volume":"67","author":"Seizures in childhood cerebral adrenoleukodystrophy","year":"2025","unstructured":"Seizures in childhood cerebral adrenoleukodystrophy. Dev Med Child Neurol. 2025;67:e134\u2013134. https:\/\/doi.org\/10.1111\/dmcn.16373.","journal-title":"Dev Med Child Neurol"},{"key":"1514_CR99","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","volume":"378","author":"A Schulz","year":"2018","unstructured":"Schulz A, Ajayi T, Specchio N, Reyes E, de Gissen L, Ballon P. Study of Intraventricular Cerliponase Alfa for CLN2 Disease. New Engl J Med Mass Med Soc. 2018;378:1898\u2013907. https:\/\/doi.org\/10.1056\/NEJMoa1712649.","journal-title":"New Engl J Med Mass Med Soc"},{"key":"1514_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1516026","volume":"16","author":"A Schulz","year":"2025","unstructured":"Schulz A, Schwering C, Wibbeler E, Westermann LM, Hagenah L, Lezius S, et al. Real-world clinical outcomes of patients with CLN2 disease treated with cerliponase alfa. Front Neurol. 2025;16:1516026. https:\/\/doi.org\/10.3389\/fneur.2025.1516026.","journal-title":"Front Neurol"},{"key":"1514_CR101","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/cts.12925","volume":"14","author":"A Kim","year":"2021","unstructured":"Kim A, Grover A, Hammon K, de Hart G, Slasor P, Cherukuri A, et al. Clinical pharmacokinetics and pharmacodynamics of cerliponase alfa, enzyme replacement therapy for CLN2 disease by intracerebroventricular administration. Clin Transl Sci. 2021;14:635\u201344. https:\/\/doi.org\/10.1111\/cts.12925.","journal-title":"Clin Transl Sci"},{"key":"1514_CR102","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/08830738251389180","volume":"41","author":"JA Oliveira","year":"2026","unstructured":"Oliveira JA, Saddique MN, Qadri M, Shahid F, de Jesus ACFS, Sarmento FP. Treatment of Neuronal Ceroid Lipofuscinosis Type 2 with Cerliponase Alfa: A Systematic Review and Single-Arm Meta-Analysis of Two Studies. J Child Neurol SAGE Publications Inc. 2026;41:430\u20136. https:\/\/doi.org\/10.1177\/08830738251389180.","journal-title":"J Child Neurol SAGE Publications Inc"},{"key":"1514_CR103","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S1474-4422(23)00384-8","volume":"23","author":"A Schulz","year":"2024","unstructured":"Schulz A, Specchio N, Reyes E, de los, Gissen P, Nickel M, Trivisano M, et al. Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study. Lancet Neurol Elsevier. 2024;23:60\u201370. https:\/\/doi.org\/10.1016\/S1474-4422(23)00384-8.","journal-title":"Lancet Neurol Elsevier"},{"key":"1514_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-42150-6","author":"R Posset","year":"2026","unstructured":"Posset R, Epp F, Garbade SF, Gleich F, Gropman AL, Nagamani SCS, et al. Impact of long-term nitrogen scavenger therapy on clinical outcome in individuals with urea cycle disorders. Sci Rep. 2026. https:\/\/doi.org\/10.1038\/s41598-026-42150-6.","journal-title":"Sci Rep"},{"key":"1514_CR105","doi-asserted-by":"publisher","DOI":"10.1111\/gtc.70115","volume":"31","author":"Y Hayase","year":"2026","unstructured":"Hayase Y, Owa T, Hashizume K, Suyama K, Bolorbat T, Sone M, et al. Pharmacological correction of aberrant DSCAML1 localization by 4-phenylbutyrate ameliorates epileptic phenotypes in a mouse model harboring the patient-specific A2105T mutation. Genes Cells. 2026;31:e70115. https:\/\/doi.org\/10.1111\/gtc.70115.","journal-title":"Genes Cells"},{"key":"1514_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2025.107621","volume":"217","author":"A Stone","year":"2025","unstructured":"Stone A, Burr\u00e9 J, Wayland N, Grinspan ZM. Phenylbutyrate for monogenetic epilepsy: literature review. Epilepsy Res. 2025;217:107621. https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107621.","journal-title":"Epilepsy Res"},{"key":"1514_CR107","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214110","volume":"105","author":"N Pietrafusa","year":"2025","unstructured":"Pietrafusa N, Trivisano M, Calabrese C, De Dominicis A, Cappelletti S, Correale C, et al. Long-term open-label study evaluating oral miglustat treatment in patients with neuronal ceroid lipofuscinosis type 3. Neurology. 2025;105:e214110. https:\/\/doi.org\/10.1212\/WNL.0000000000214110.","journal-title":"Neurology"},{"key":"1514_CR108","doi-asserted-by":"publisher","first-page":"e614","DOI":"10.1212\/NXG.0000000000000614","volume":"7","author":"IH Quraishi","year":"2021","unstructured":"Quraishi IH, Szekely AM, Shirali AC, Mistry PK, Hirsch LJ. Miglustat Therapy for SCARB2-Associated Action Myoclonus\u2013Renal Failure Syndrome. Neurol Genet. 2021;7:e614. https:\/\/doi.org\/10.1212\/NXG.0000000000000614.","journal-title":"Neurol Genet"},{"key":"1514_CR109","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.chembiol.2020.08.012","volume":"28","author":"X-J Di","year":"2021","unstructured":"Di X-J, Wang Y-J, Cotter E, Wang M, Whittsette AL, Han D-Y, et al. Proteostasis Regulators Restore Function of Epilepsy-Associated GABAA Receptors. Cell Chem Biology. 2021;28:46\u2013e597. https:\/\/doi.org\/10.1016\/j.chembiol.2020.08.012.","journal-title":"Cell Chem Biology"},{"key":"1514_CR110","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/WCO.0000000000001349","volume":"38","author":"MC Walker","year":"2025","unstructured":"Walker MC. State-of-the-art gene therapy in epilepsy. Curr Opin Neurol. 2025;38:128\u201334. https:\/\/doi.org\/10.1097\/WCO.0000000000001349.","journal-title":"Curr Opin Neurol"},{"key":"1514_CR111","doi-asserted-by":"publisher","first-page":"eaaz6100","DOI":"10.1126\/scitranslmed.aaz6100","volume":"12","author":"Z Han","year":"2020","unstructured":"Han Z, Chen C, Christiansen A, Ji S, Lin Q, Anumonwo C, et al. Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome. Sci Transl Med. 2020;12:eaaz6100. https:\/\/doi.org\/10.1126\/scitranslmed.aaz6100.","journal-title":"Sci Transl Med"},{"key":"1514_CR112","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJMoa2506295","volume":"394","author":"L Laux","year":"2026","unstructured":"Laux L, Sullivan J, Perry MS, Brunklaus A, Desurkar A, Schreiber JM, et al. Zorevunersen in Children and Adolescents with Dravet Syndrome. N Engl J Med. 2026;394:969\u201382. https:\/\/doi.org\/10.1056\/NEJMoa2506295.","journal-title":"N Engl J Med"},{"issue":"26","key":"1514_CR113","doi-asserted-by":"publisher","first-page":"00209","DOI":"10.1016\/j.ymthe.2026.03.027","volume":"S1525\u20130016","author":"NB Gallo","year":"2026","unstructured":"Gallo NB, Annand JW, Clarner P, Harvey B, Morozova E, Ehrenfels C, et al. Identification of a therapeutic threshold for AAV-STXBP1 gene therapy in a rodent model of STXBP1 developmental and epileptic encephalopathy. Mol Ther. 2026;S1525\u20130016(26):00209\u20131. https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.027.","journal-title":"Mol Ther"},{"key":"1514_CR114","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1016\/j.ymthe.2025.05.011","volume":"33","author":"R Aeran","year":"2025","unstructured":"Aeran R, Tanenhaus A, Sears SMS, Moerke NJ, Miller A, Artur C, et al. Neuron-targeted gene therapy rescues multiple phenotypes of STXBP1-related disorders in mice and is well tolerated in nonhuman primates. Mol Ther. 2025;33:3822\u201340. https:\/\/doi.org\/10.1016\/j.ymthe.2025.05.011.","journal-title":"Mol Ther"},{"key":"1514_CR115","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2026.1021","author":"E Sherrill","year":"2026","unstructured":"Sherrill E, Cheerie D, Beck CJ, Whittle EF, Shafi Y, Chandler NJ, et al. Precision antisense oligonucleotide therapy amenability for infantile genetic epilepsies. JAMA Neurol. 2026. https:\/\/doi.org\/10.1001\/jamaneurol.2026.1021.","journal-title":"JAMA Neurol"},{"key":"1514_CR116","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41431-025-01820-1","volume":"33","author":"A Bruselles","year":"2025","unstructured":"Bruselles A, Mancini C, Chiriatti L, Carvetta M, Baroni MC, Cappelletti C, et al. Expanding the mutational spectrum of ReNU syndrome: insights into 5\u2019 Stem-loop variants. Eur J Hum Genet. 2025;33:432\u201340. https:\/\/doi.org\/10.1038\/s41431-025-01820-1.","journal-title":"Eur J Hum Genet"},{"key":"1514_CR117","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.tig.2024.09.005","volume":"40","author":"VF Burns","year":"2024","unstructured":"Burns VF, Radford EJ. ReNU syndrome \u2013 a newly discovered prevalent neurodevelopmental disorder. Trends in Genetics. Elsevier. 2024;40:914\u20136. https:\/\/doi.org\/10.1016\/j.tig.2024.09.005.","journal-title":"Elsevier"},{"key":"1514_CR118","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/s41588-025-02159-5","volume":"57","author":"D Greene","year":"2025","unstructured":"Greene D, De Wispelaere K, Lees J, Codina-Sol\u00e0 M, Jensson BO, Hales E, et al. Mutations in the small nuclear RNA gene RNU2-2 cause a severe neurodevelopmental disorder with prominent epilepsy. Nat Genet Nat Publishing Group. 2025;57:1367\u201373. https:\/\/doi.org\/10.1038\/s41588-025-02159-5.","journal-title":"Nat Genet Nat Publishing Group"},{"key":"1514_CR119","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41586-024-07773-7","volume":"632","author":"Y Chen","year":"2024","unstructured":"Chen Y, Dawes R, Kim HC, Ljungdahl A, Stenton SL, Walker S, et al. De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome. Nat Nat Publishing Group. 2024;632:832\u201340. https:\/\/doi.org\/10.1038\/s41586-024-07773-7.","journal-title":"Nat Nat Publishing Group"},{"key":"1514_CR120","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.seizure.2026.01.010","volume":"135","author":"M Mastrangelo","year":"2026","unstructured":"Mastrangelo M, Tolve M, Valenzuela I, Lentini G, Cinnante EMC, Masotto B, et al. Epilepsy phenotypes of Renu syndrome: Novel insights from a European multicentre retrospective cohort study. Seizure: Eur J Epilepsy. 2026;135:46\u201355. https:\/\/doi.org\/10.1016\/j.seizure.2026.01.010.","journal-title":"Seizure: Eur J Epilepsy"},{"key":"1514_CR121","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41588-026-02539-5","volume":"58","author":"D Greene","year":"2026","unstructured":"Greene D, Mendez R, Lees J, Barbosa M, Bruselles A, Chiriatti L, et al. Biallelic variants in RNU2-2 cause the most prevalent known recessive neurodevelopmental disorder. Nat Genet. 2026;58:774\u201381. https:\/\/doi.org\/10.1038\/s41588-026-02539-5.","journal-title":"Nat Genet"},{"key":"1514_CR122","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/ajmgb.70004","volume":"201","author":"PF Ajmone","year":"2026","unstructured":"Ajmone PF, Rigamonti C, Brasca F, Milani D, Ortigosa CR, Iascone M, et al. Longitudinal behavior phenotype hallmarks in RNU4-2 syndrome: implications for clinical management. Am J Med Genet B Neuropsychiatr Genet. 2026;201:205\u201311. https:\/\/doi.org\/10.1002\/ajmgb.70004.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1514_CR123","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41588-026-02547-5","volume":"58","author":"E Leit\u00e3o","year":"2026","unstructured":"Leit\u00e3o E, Santini A, Cogne B, Essid M, Athanasiadou M, LaFlamme CW, et al. Systematic analysis of snRNA genes reveals frequent RNU2-2 variants in dominant and recessive developmental and epileptic encephalopathies. Nat Genet. 2026;58:782\u201397. https:\/\/doi.org\/10.1038\/s41588-026-02547-5.","journal-title":"Nat Genet"},{"key":"1514_CR124","doi-asserted-by":"publisher","DOI":"10.64898\/2026.01.26.701822","volume-title":"Activating Ras-MAPK pathway variants drive hippocampal clonal competition in human epilepsy","author":"S Khoshkhoo","year":"2026","unstructured":"Khoshkhoo S, Bae M, Wang Y, Tillett A, Ramirez RB, Finander B, et al. Activating Ras-MAPK pathway variants drive hippocampal clonal competition in human epilepsy. bioRxiv: The Preprint Server for Biology; 2026. https:\/\/doi.org\/10.64898\/2026.01.26.701822."},{"key":"1514_CR125","doi-asserted-by":"publisher","DOI":"10.64898\/2026.04.06.716727","volume-title":"Somatic variants activating the RAS-MAPK pathway confer susceptibility to hippocampal sclerosis in drug-resistant epilepsy","author":"L Mashburn-Warren","year":"2026","unstructured":"Mashburn-Warren L, Holub A, Sran S, Ramadesikan S, Suh KR, Thompson A, et al. Somatic variants activating the RAS-MAPK pathway confer susceptibility to hippocampal sclerosis in drug-resistant epilepsy. bioRxiv: The Preprint Server for Biology; 2026. https:\/\/doi.org\/10.64898\/2026.04.06.716727."},{"key":"1514_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/genes12091316","volume":"12","author":"DI Battaglia","year":"2021","unstructured":"Battaglia DI, Gambardella ML, Veltri S, Contaldo I, Chillemi G, Veredice C, et al. Epilepsy and BRAF mutations: phenotypes, natural history and genotype-phenotype correlations. Genes (Basel). 2021;12:1316. https:\/\/doi.org\/10.3390\/genes12091316.","journal-title":"Genes (Basel)"},{"key":"1514_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15212690","volume":"15","author":"R Kravljanac","year":"2025","unstructured":"Kravljanac R, Be\u0111ik J, Bruno I, Vu\u010deti\u0107 Tadi\u0107 B, Popovi\u0107 S, Oparnica V, et al. Clinical characteristics of seizures and course of epilepsy in children with neurofibromatosis type 1\u2014a tertiary center experience in a cohort of 118 children. Diagnostics (Basel). 2025;15:2690. https:\/\/doi.org\/10.3390\/diagnostics15212690.","journal-title":"Diagnostics (Basel)"},{"key":"1514_CR128","doi-asserted-by":"publisher","first-page":"107476","DOI":"10.1016\/j.eplepsyres.2024.107476","volume":"208","author":"F Wu","year":"2024","unstructured":"Wu F, Ji X, Shen M, Cheng P, Gao Y, Liu W, et al. Prevalence, clinical characteristics and outcomes of seizures in neurofibromatosis type 1: A systematic review and single arm meta-analysis. Epilepsy Res. 2024;208:107476. https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107476.","journal-title":"Epilepsy Res"},{"key":"1514_CR129","doi-asserted-by":"publisher","first-page":"2329048X2211314","DOI":"10.1177\/2329048X221131445","volume":"9","author":"AM Khair","year":"2022","unstructured":"Khair AM, Falchek S, Nikam R, Kaur G. Epilepsy and Electroencephalogram Characteristics in Children with Neurofibromatosis Type 1, What We Have Learned from a Tertiary Center Five Years\u2019 Experience. Child Neurol Open SAGE Publications Inc. 2022;9:2329048X221131445. https:\/\/doi.org\/10.1177\/2329048X221131445.","journal-title":"Child Neurol Open SAGE Publications Inc"},{"key":"1514_CR130","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s00381-020-04710-7","volume":"36","author":"P Bernardo","year":"2020","unstructured":"Bernardo P, Cinalli G, Santoro C. Epilepsy in NF1: a systematic review of the literature. Childs Nerv Syst. 2020;36:2333\u201350. https:\/\/doi.org\/10.1007\/s00381-020-04710-7.","journal-title":"Childs Nerv Syst"},{"key":"1514_CR131","doi-asserted-by":"publisher","unstructured":"Lemus AM, Boelman C, Myers KA. Epilepsy in Legius syndrome: coincidence or causation? Am J Med Genet A. 2024(6). https:\/\/doi.org\/10.1002\/ajmg.a.63547.","DOI":"10.1002\/ajmg.a.63547"},{"key":"1514_CR132","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/epd2.20180","volume":"26","author":"S Barri\u00e8re","year":"2024","unstructured":"Barri\u00e8re S, Faure-Conter C, Leblond P, Philippe M, des Portes V, Lion Fran\u00e7ois L, et al. Antiseizure effect of MEK inhibitor in a child with neurofibromatosis type 1-Developmental and epileptic encephalopathy and optic pathway glioma. Epileptic Disord. 2024;26:133\u20138. https:\/\/doi.org\/10.1002\/epd2.20180.","journal-title":"Epileptic Disord"},{"key":"1514_CR133","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s00381-022-05571-y","volume":"38","author":"E Cantor","year":"2022","unstructured":"Cantor E, Meyer A, Morris SM, Weisenberg JLZ, Brossier NM. Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1. Childs Nerv Syst. 2022;38:2245\u20139. https:\/\/doi.org\/10.1007\/s00381-022-05571-y.","journal-title":"Childs Nerv Syst"},{"key":"1514_CR134","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pediatrneurol.2023.08.019","volume":"148","author":"G D\u2019Onofrio","year":"2023","unstructured":"D\u2019Onofrio G, Delrue M-A, Lortie A, Marquis C, Striano P, Jaworski M, et al. Treatment of Refractory Epilepsy With MEK Inhibitor in Patients With RASopathy. Pediatr Neurol. 2023;148:148\u201351. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2023.08.019.","journal-title":"Pediatr Neurol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01514-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-026-01514-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01514-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:58:01Z","timestamp":1789030681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-026-01514-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":134,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1514"],"URL":"https:\/\/doi.org\/10.1007\/s11910-026-01514-1","relation":{},"ISSN":["1534-6293"],"issn-type":[{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"17 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No animal or human subjects by the authors were used in this study.","order":2,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"44"}}